Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT [Phase 1]
Phase 1 trial evaluating multi-virus cytotoxic T lymphocytes engineered with CD19 chimeric receptors for CD19-positive malignancies after st…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System [Phase 1]
Phase 1 trial investigating safety and activity of a novel TNFR2 inhibitor in adults with non-Hodgkin lymphoma, including cutaneous T-cell l…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant [Phase 2]
A Phase II randomized trial evaluating hyperbaric oxygen to improve engraftment after umbilical cord blood stem cell transplantation in pati…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial evaluating human anti-CD19 CAR-T cells for relapsed or refractory lymphoid malignancies is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR) [Phase 1]
Phase 1 study update for CD19 CAR-allogeneic NKT therapy (ANCHOR) in relapsed or refractory B-cell malignancies; the trial is currently acti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma [Phase 4]
Phase 4 trial assessing immunogenicity of a pneumococcal vaccination strategy in adults treated for Non-Hodgkin lymphoma, comparing PCV13+PP…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma [Phase 1]
Phase 1 clinical trial evaluating venetoclax with BEAM conditioning before autologous stem cell transplant in Non-Hodgkin lymphoma; currentl…
-
CLINICAL_TRIALS trial_result · 2025-06-27Clinical Trial Update: Cardiotoxicity and Other Late Effects After Radiotherapy and Immuno-chemoTherapy in Non-Hodgkin lYmphoma
This completed trial update reports on cardiotoxicity and other late effects after radiotherapy combined with immuno-chemotherapy in non-Hod…
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
A clinical trial update describes evaluating 68Ga-Pentixafor PET/MR for detecting lesions in non-Hodgkin lymphoma and multiple myeloma; the …
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Avelumab With Valproic Acid in Virus-associated Cancer [Phase 2]
Phase 2 trial evaluating the PD-L1 inhibitor avelumab in combination with valproic acid for virus-associated cancers has completed; the upda…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL [Phase 2]
Phase 2 clinical trial of Paxalisib (GDC-0084) for recurrent or refractory primary central nervous system lymphoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating obinutuzumab with GDP chemotherapy in relapsed or refractory non-Hodgkin lymphoma has completed enrollment.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [Phase 1]
This update covers the completed Phase 1 study of the investigational drug JNJ-67856633 in participants with non-Hodgkin lymphoma and chroni…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Treatment and Natural History Study of Lymphomatoid Granulomatosis [Phase 2]
This is a Phase 2 clinical trial update reporting results for a treatment and natural history study of lymphomatoid granulomatosis; results …
-
EMA approval · 2025-06-18EMA Authorised: Phelinun (melphalan hydrochloride) — ADIENNE S.r.l. S.U.
The EMA authorised Phelinun (melphalan hydrochloride) for multiple cancers including multiple myeloma, Hodgkin lymphoma, non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: A Phase 1 Study of ADI-001 in B Cell Malignancies [Phase 1]
The Phase 1 study of ADI-001 in B cell malignancies has been terminated.
-
FDA approval · 2025-06-16FDA Approved: PLERIXAFOR — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic version of plerixafor (Mozobil) for mobilizing hematopoietic stem cells in adults with non-Hodgkin lymphoma or multip…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases [Phase 2]
A Phase 2 clinical trial is testing alpha/beta T cell and CD19+ B cell depletion in allogeneic stem cell transplantation for malignant disea…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma [Phase 2]
Phase 2 clinical trial evaluating chemoradiotherapy with targeted immunotherapy for pediatric lymphomas. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health [NA]
This clinical trial update from the University of Alabama at Birmingham describes a study evaluating multiple behavior interventions to impr…
-
CLINICAL_TRIALS withdrawal · 2025-06-12Clinical Trial Update: Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. [NA]
A clinical trial evaluating Triamcinolone acetonide injections with a novel needle-free delivery system for primary cutaneous lymphoma plaqu…
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Brentuximab Vedotin With or Without Nivolumab in Treating Patients With Relapsed or Refractory CD30+ Lymphoma [Phase 2]
Clinical trial update for a Phase 2 study evaluating brentuximab vedotin with or without nivolumab in patients with relapsed or refractory C…
-
CLINICAL_TRIALS other · 2025-06-09Clinical Trial Update: A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas [Phase 1]
A Phase 1 study of ATG-101 in patients with metastatic/advanced solid tumors and mature B-cell non-Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating isatuximab during stem cell collection and subsequent transplant in patients with multiple myeloma an…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Palifermin (Kepivance) in patients undergoing unrelated donor allogeneic hematopoietic cell transplant…